Drug and Alcohol Dependence
Volume 91, Issue 2 , Pages 220-227 , 1 December 2007

A randomized clinical trial of methadone maintenance for prisoners: Results at 1-month post-release

  • Timothy W. Kinlock

      Affiliations

    • Social Research Center, Friends Research Institute, Baltimore, MD 21201, USA
    • Division of Criminology, Criminal Justice, and Social Policy, University of Baltimore, Baltimore, MD 21201, USA
    • Corresponding Author InformationCorresponding author at: Social Research Center, Friends Research Institute, Baltimore, MD 21201, USA. Tel.: +1 410 837 3977x224; fax: +1 410 752 4218.
    • ,
  • Michael S. Gordon

      Affiliations

    • Social Research Center, Friends Research Institute, Baltimore, MD 21201, USA
    • ,
  • Robert P. Schwartz

      Affiliations

    • Social Research Center, Friends Research Institute, Baltimore, MD 21201, USA
    • Open Society Institute-Baltimore, Baltimore, MD 21201, USA
    • ,
  • Kevin O’Grady

      Affiliations

    • Department of Psychology, University of Maryland, College Park, MD 20742, USA
    • ,
  • Terrence T. Fitzgerald

      Affiliations

    • Man Alive Inc., Baltimore, MD 21218, USA
    • ,
  • Monique Wilson

      Affiliations

    • Social Research Center, Friends Research Institute, Baltimore, MD 21201, USA

Received 28 March 2007 ,Revised 25 May 2007 ,Accepted 30 May 2007.

References 

  1. Agresti A. Categorical Data Analysis. New York: Wiley; 1990;
  2. American Association for the Treatment of Opioid Dependence, 2001. AATOD's Five-Year Plan for Methadone Treatment in the United States. http://www.aatod.org/policy_five_year.html.
  3. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; 1994;
  4. Anglin MD. The efficacy of civil commitment in treating narcotic addiction. Natl. Inst. Drug Abuse Res. Monogr. 1988;86:8–34
  5. Ball JC, Ross A. The Effectiveness of Methadone Maintenance Treatment: Patients, programs, Services, and Outcomes. New York, NY: Springer; 1991;
  6. Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, et al. Release from prison—a high risk of death for former inmates. N. Engl. J. Med. 2007;356:157–165
  7. Bird SM, Hutchinson SJ. Male drugs-related deaths in the fortnight after release from prison, Scotland, 1996–99. Addiction. 2003;98:185–190
  8. Chaiken JM. Correctional Population of the United States, 1997. Washington, DC: National Institute of Justice, Bureau of Justice Statistics; 2000;(NCJ Publication no. 177613)
  9. Chaiken JM, Chaiken MR. Drugs and predatory crime. In:  Tonry M,  Wilson JQ editor. Crime and Justice: Drug and Crime. vol. 13:Chicago: University of Chicago Press; 1990;p. 203–219
  10. Chitwood D, Comerford M, Weatherby N. The initiation and use of heroin in the age of crack. In:  Inciardi JA,  Harrison LD editor. Heroin in the Age of Crack-cocaine. Thousand Oaks, CA: Sage; 1998;p. 51–76
  11. Dolan KA. Can hepatitis C transmission be reduced in Australian prisons?. Med. J. Aust. 2001;174:378–379
  12. Dolan KA, Shearer J, White B, Zhou J, Kaldor J, Wodak AD. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration, and hepatitis C infection. Addiction. 2005;100:820–828
  13. Dole VP, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction: a clinical trial with methadone hydrochloride. JAMA. 1965;193:80–84
  14. Dole V, Robinson J, Orraga J, Towns E, Searcy P, Caine E. Methadone treatment of randomly selected criminal addicts. N. Eng. J. Med. 1969;280:1372–1375
  15. Edlin BR. Prevention and treatment of hepatitis C in injection drug users. Hepatology. 2002;36:S210–S219
  16. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2002. Annual Report. Brussels.
  17. Field G. Continuity of Offender Treatment for Substance Abuse Disorders from Institution to Community. Rockville, MD: Center for Substance Abuse Treatment; 1998;[Treatment improvement protocol (TIP) series 30, DHHS Publication no. (SMA) 98-3245]
  18. Fuller C, Vlahov D, Safaeian M, Ompad D, Strathdee SA. Correlates of HIV infection among newly initiated adolescent and young adult injection drug users. In: Paper presented at the Society for Epidemiological Research 32nd Annual Meeting. Baltimore, MD. 1999;
  19. Gray TA, Wish ED. Substance Abuse and Need for Treatment among Arrestees (SANTA) in Maryland. College Park, MD: Center for Substance Abuse Research; 2001;
  20. Hagan H, Snyder N, Hough E, Yu T, McKiernan S, Boase J, et al. Case-reporting of acute hepatitis B and C among injection drug users. J. Urban Health. 2002;79:579–585
  21. Hanlon TE, Nurco DN, Bateman RW, O’Grady KE. The response of drug abuser parolees to a combination of treatment and intensive supervision. Prison J. 1998;78:31–44
  22. Hosmer D, Lemeshow S. Applied Logistic Regression. New York: Wiley; 1989;
  23. Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch. Gen. Psychiatry. 2001;58:503–508
  24. Inciardi JA. The War on Drugs III. Boston: Allyn and Bacon; 2001;
  25. Inciardi JA, McBride D, Surratt H. The heroin street addict: profiling a national population. In:  Inciardi JA,  Harrison LD editor. Heroin in the Age of Crack-cocaine. Thousand Oaks, CA: Sage; 1998;p. 31–50
  26. Jaffe JH, Senay EC. Methadone and l-methadyl acetate: use in management of narcotic addicts. JAMA. 1971;216:1303–1305
  27. Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N. Engl. J. Med. 2000;343:1290–1297
  28. Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mt. Sinai J. Med. 2000;67:347–364
  29. Jurgens, R., 2004. Is the world finally waking up to HIV/AIDS in prisons? A report from the XV International AIDS Conference. Infectious Disease in Corrections Report 7.
  30. Karberg JC, James DJ. Substance Dependence, Abuse, and Treatment of Jail Inmates, 2002. Washington, DC: National Institute of Justice, Bureau of Justice Statistics; 2005;(NCJ Publication no. 209588)
  31. Kinlock TW, Battjes RJ, Schwartz RP. A novel opioid maintenance program for prisoners: preliminary findings. J. Subst. Abuse Treat. 2002;22:141–147
  32. Kinlock TW, Battjes RJ, Schwartz RP. A novel opioid maintenance program for prisoners: report of post-release outcomes. Am. J. Drug Alcohol Abuse. 2005;31:433–454
  33. Kinlock TW, Gordon MS. Substance abuse treatment: new research. In:  Bennett LA editors. New Topics in Substance Abuse Treatment. New York, NY: Nova Science Publishers; 2006;p. 71–111
  34. Kinlock TW, O’Grady KE, Hanlon TE. Prediction of the criminal activity of incarcerated drug-abusing offenders. J. Drug Issues. 2003;33:897–920
  35. Kinlock TW, Schwartz RP, Gordon MS. The significance of interagency collaboration in developing opioid agonist programs for inmates. Corr. Compend. 2005;30(6–9):28–30
  36. Leukefeld CG, Tims FM, Farabee D. Treatment of Drug Offenders: Policies and Issues. New York, NY: Springer; 2002;
  37. Maddux JF, Desmond DP. Careers of Opioid Users. New York, NY: Praeger; 1981;
  38. Magura S, Rosenblum A, Lewis C, Joseph H. The effectiveness of in-jail methadone maintenance. J. Drug Issues. 1993;23:75–99
  39. Mark TL, Woody GE, Juday T, Kleber HD. The economic costs of heroin addiction in the United States. Drug Alcohol Depend. 2001;61:195–206
  40. McLellan AT, Kushner H, Metzger D, Peters R, Grissom G, Pettinati H, et al. The fifth edition of the addiction severity index: historical critique and normative data. J. Subst. Abuse Treat. 1992;9:199–213
  41. McSweeney T, Turnbull PJ, Hough M. Review of Criminal Justice Interventions for Drug Use in Other Countries. London: Criminal Policy Research Unit; 2002;
  42. Nurco DN. A long-term program of research on drug use and crime. Subst. Use Misuse. 1998;33:1817–1837
  43. Nurco DN, Hanlon TE, Kinlock TW. Recent research on the relationship between illicit drug use and crime. Behav. Sci. Law. 1991;9:221–242
  44. Office of National Drug Control Policy (ONDCP), 2001. The National Drug Control Strategy Annual Report. Executive Office of the President, Office of National Drug Control Policy, Washington, DC.
  45. Office of National Drug Control Policy, 2001. The National Drug Control Strategy Annual Report, Washington, DC.
  46. Pelissier B, Jones N. A review of gender differences among substance abusers. Crime Delinquency. 2005;51:345–372
  47. Platt JJ, Widman M, Lidz V, Marlow D. Methadone maintenance treatment: its development and effectiveness after 30 years. In:  Inciardi JA,  Harrison LD editor. Heroin in the Age of Crack-Cocaine. Thousand Oaks, CA: Sage; 1998;p. 160–187
  48. Rezza G, Scalia Tomba G, Martucci P, Massella M, Noto R, DeRisio A, et al. Prevalence of the use of old and new drugs among entrants in Italian prisons. Ann. 1st Super. Sanita. 2005;41:239–245
  49. Schwartz RP, Highfield DA, Jaffe JH, Brady JV, Butler CA, Rouse CO, et al. A randomized controlled trial of interim methadone maintenance. Arch. Gen. Psychiatry. 2006;63:102–109
  50. Smith-Rohrberg D, Bruce RD, Altice FL. Research note-review of corrections-based therapy for opiate-dependent patients: implications for buprenorphine dependence among correctional populations. J. Drug Issues. 2004;34:451–480
  51. Stewart LM, Henderson CJ, Hobbs MS, Ridout SC, Knuiman MW. Risk of death in prisoners after release from jail. Aust. N. Z. J. Public Health. 2004;28:32–36
  52. Strang J, Gossop M, Heuston J, Green J, Whiteley C, Maden A. Persistence of drug use during imprisonment: relationship of drug type, recency of use and severity of dependence to use of heroin, cocaine, and amphetamine in prison. Addiction. 2006;101:1125–1132
  53. Substance Abuse and Mental Health Services Administration . Year-end 1999 Emergency Department Data from the Drug Abuse Warning Network. Rockville, MD: SAMHSA; 2000;
  54. Tomasino V, Swanson AJ, Nolan J, Shuman HI. The key extended entry program (KEEP): a methadone treatment program for opiate-dependent inmates. Mt. Sinai J. Med. 2001;68:14–20
  55. Weatherburn D, Lind B. Heroin harm minimization: do we really have to choose between law enforcement and treatment?. N. S. Wales Crime Justice Bull. 1999;46:1–11
  56. Wish ED, Yacoubian GS. Findings from the Baltimore City Substance Abuse Need for Treatment (SANTA) Project, 2001. College Park, MD: Center for Substance Abuse Research; 2001;

☆ Funding for this study was provided by Grant R01 DA 16237 from the National Institute on Drug Abuse (NIDA) and awarded to the first author; the NIDA had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.

PII: S0376-8716(07)00232-3

doi: 10.1016/j.drugalcdep.2007.05.022

Drug and Alcohol Dependence
Volume 91, Issue 2 , Pages 220-227 , 1 December 2007

Article Tools

* Image Usage & Resolution